Literature DB >> 2015164

Uses and misuses of definitions of genetic polymorphism. A perspective from population pharmacogenetics.

T D Arias, L F Jorge, R Barrantes.   

Abstract

Mesh：

Year:  1991        PMID： 2015164      PMCID： PMC1368425          DOI： 10.1111/j.1365-2125.1991.tb03870.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  Poor metabolisers of debrisoquine reveal their true colours.

Authors:  J R Idle
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

2.  Disassociation between debrisoquine hydroxylation phenotype and genotype among Chinese.

Authors:  Q Y Yue; L Bertilsson; M L Dahl-Puustinen; J Säwe; F Sjöqvist; I Johansson; M Ingelman-Sundberg
Journal:  Lancet       Date:  1989-10-07       Impact factor: 79.321

3.  No evidence for the presence of poor metabolizers of sparteine in an Amerindian group: the Cunas of Panama.

Authors:  T D Arias; L F Jorge; T Inaba
Journal:  Br J Clin Pharmacol       Date:  1986-05       Impact factor: 4.335

4.  The detection of polymorphic drug oxidation--some theoretical and practical aspects.

Authors:  G T Tucker; P R Jackson; M S Lennard; H F Woods
Journal:  Prog Clin Biol Res       Date:  1986

5.  Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians.

Authors:  N M Woolhouse; M Eichelbaum; N S Oates; J R Idle; R L Smith
Journal:  Clin Pharmacol Ther       Date:  1985-05       Impact factor: 6.875

6.  Pharmacoanthropology: outline, problems, and the nature of case histories.

Authors:  W Kalow
Journal:  Fed Proc       Date:  1984-05-15

7.  Human pharmacogenetics: Introduction.

Authors:  R M Weinshilboum
Journal:  Fed Proc       Date:  1984-05-15

8.  A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin.

Authors:  E Steiner; L Iselius; G Alván; J Lindsten; F Sjöqvist
Journal:  Clin Pharmacol Ther       Date:  1985-10       Impact factor: 6.875

9.  Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans.

Authors:  M Eichelbaum; N M Woolhouse
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

10.  Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation.

Authors:  A O Iyun; M S Lennard; G T Tucker; H F Woods
Journal:  Clin Pharmacol Ther       Date:  1986-10       Impact factor: 6.875
View more
  3 in total

1.  Pharmacogenetics in Ghana: reviewing the evidence.

Authors:  W Kudzi; G O Adjei; D Ofori-Adjei; A N O Dodoo
Journal:  Ghana Med J       Date:  2011-06

Review 2.  Transcription Factor AP4 Mediates Cell Fate Decisions: To Divide, Age, or Die.

Authors:  Matthew Man-Kin Wong; Sancy Mary Joyson; Heiko Hermeking; Sung Kay Chiu
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

3.  Inferring intelligence of ancient people based on modern genomic studies.

Authors:  Kaisar Dauyey; Naruya Saitou
Journal:  J Hum Genet       Date:  2022-05-09       Impact factor: 3.755
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.